Advancements in sequencing technologies, increasing benefits and applications of Sanger Sequencing, and progress in genomics research are some key factors expected to drive market growth
Sanger sequencing services provide high-quality, fast turnaround times, and robust customer services. Sanger sequencing services have helped streamline genomics and molecular biology research by answering complicate research questions for a wide range of topics including membrane trafficking, CRISPR interference, and tumor mutations, among others. Increasing application of Sanger sequencing and rising investment to expand R&D activities are key factors expected to drive market revenue growth over the forecast period.
Sanger sequencing is a first-generation DNA sequencing method and has a crucial place in clinical genomics for confirming sequence variants that are identified by NGS and covers the sequences that are not entirely covered by NGS. Sanger sequencing is also known as chain termination method and is one of most widely used for detection of single nucleotide variants (SNVs). Application of Sanger sequencing to backfill NGs data needs efficient integration of NGS and Sanger data for analysis and reporting purposes.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/789
This can pose a challenge as these data are obtained by various methods and sequencing services help overcome these challenges by offering high-quality analysis. Sanger sequencing services cover a broad range of services from single reads to complete double strand sequences. These services can streamline and simplify genomics workflow, provide advanced assay kits, and offer superior quality data analysis reports in shorter time. Increasing demand for these comprehensive services have further compelled key companies to offer robust services for routine sequencing of plasmids and PCR products. This is expected to further contribute to revenue growth of the market going ahead.
However, lack of skilled professionals and unavailability of standardized protocols for sequencing methods are expected to hamper market growth to a significant extent over the forecast period.
COVID-19 Impact Analysis
- The virus outbreak and social distancing norms and restrictions severely disrupted the overall business landscape and operations worldwide.
- COVID-19 pandemic and lockdowns have resulted in several countries shutting down airports, ports, and commercial and domestic transportation. This had impacted manufacturing activities and operations globally and took a toll on the economy of various countries.
- Sudden and drastic downturn in economic activity caused a slowdown in manufacturing, production, import/export, and other sectors and also resulted in employment loss to a major extent.
- Supply impacts were further compounded due to challenges on the demand-side owing to reduced disposable income, depleting savings, and increased concerns and uncertainties.
- Emergence of variants of the virus and rise in infection rates during the initial waves and subsequent lockdowns has severely impacted operations and disrupted supply chains.
Increasing Application of Sanger Sequencing for Cancer Biomarker Identification:
Biomarkers and cancer segment is expected to account for largest revenue share over the forecast period attributable to rapid progress of oncology research and increasing use of Sanger sequencing for discovery and identification of cancer biomarkers and understand the carcinogenesis.
Check Our Prices@ https://www.emergenresearch.com/select-license/789
Pharmaceutical & Biotechnology Companies Segment to Dominate other End-use Segments:
Pharmaceutical & biotechnology companies segment is expected to dominate other end-use segments in terms of revenue growth over the forecast period attributed to increasing application of Sanger sequencing for tumor profiling and identification of genetic variations, rising investment to accelerate genomics research, and rising number of genome mapping programs.
North America to Lead in Terms of Revenue Share:
North America is expected to account for largest revenue share over the forecast period owing to extensive molecular biology and genomics R&D activities, presence of major pharmaceutical and biotechnology companies, growing incidence of cancer and genetic disorders, and establishment of robust research facilities in the region.
Major Companies in the Market Include:
- Source BioScience
- GenScript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- LGC Science Group Limited
- Fasteris SA
- CeMIA SA
- Quintara Biosciences
- GenHunter Corporation
- SciGenom Labs Pvt. Limited,
- Microsynth AG. Inc.
For the purpose of this report, Emergen Research has segmented the global Sanger sequencing services market on the basis of application, end-use, and region:
Application Outlook (Revenue, USD Billion; 2018-2028)
- Biomarkers & Cancer
- Reproductive Health
- Personalized Medicine
End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/sanger-sequencing-services-market
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Take a Look at our Related Reports:
Smart Stethoscope Market Analysis By Type (Wireless Stethoscope, Wired Stethoscope), By Application (Hospitals, Ambulatory Surgical Units, Clinics, Others), By End Use, By Region, Forecast to 2027
Smart Gloves Market Analysis By Usage (Media and Connected Device, Fitness Tracker, Specific Health Monitoring Device, Others), By End-user (Healthcare, Fitness, Industrial, Others), By Region, Forecast to 2027
Retinal Imaging Market Analysis By Device Type (Fundus Camera, Fluorescein Angiography, Optical Coherence Tomography (OCT)), By End-user (Hospitals, Clinics, Ophthalmic Centers, Ambulatory Surgical Centers, Others), By Region, Forecast to 2027
Predictive Biomarkers Market Analysis By Product Type (Cancer, Neurological Disorders, Immunological Disorders, Cardiovascular Disorders, Others), By Application (Diagnostic Centers, Academic and Research Institute, Others), By End User, By Region, Forecast to 2027
Hydralazine Market Analysis By Type (Tablet, Injection), By Application (Hospital, Clinics, Diagnostic Centers, Recovery Centers, Others), By End Use, By Region, Forecast to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/industry-report/sanger-sequencing-services-market